JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
47 hedge funds and large institutions have $51.2M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% more funds holding
Funds holding: 36 → 47 (+11)
Holders
47
Holding in Top 10
1
Calls
$682K
Puts
$1K
Top Buyers
| 1 | +$1.52M | |
| 2 | +$1.26M | |
| 3 | +$1.25M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$866K |
| 5 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$812K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$1.06M | |
| 3 | -$1.02M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$560K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$69.8K |